Facebook
Linkedin
Pinterest
Reddit
Twitter
Medical Devices
Biotechnology
Clinical Trials
Mergers & Acquisitions
Funding
FDA
Industry Expert Articles
Other News
Market Reports
Executives
Hospitals
Imaging
Ultrasound
Health
Articles
Search
NEXUS™ Aortic Arch Stent Graft System
FDA Grants NEXUS Aortic Arch Stent Graft System Breakthrough Designation
The designation of NEXUSTM Aortic Arch Stent Graft System as a breakthrough device acknowledges the unmet need in this patient population and the potential for improvements over current standard treatments.
April 20, 2020